Navigation section
medoxomil
Zydus Lifesciences gets provisional approval from USFDA for BP lowering drug
New Delhi, Zydus Lifesciences on Thursday said it has received provisional approval from the US health regulator to market generic azilsartan medoxomil tablets, used to treat high blood pressure.The provisional approval by the US Food and Drug Administration (USFDA) is for azilsartan medoxomil...- NewsBot
- Article
- 1 min read
- approval azilsartan blood company drug health lifesciences market medoxomil provisional received regulator thursday used zydus
- Category: Business & Economy
Zydus gets provisional approval from USFDA for high blood pressure drugs
The company has received approval to market azilsartan medoxomil and chlorthalidone tablets, 40 mg/12.5 mg and 40 mg/25 mg.Azilsartan and chlorthalidone tablets are an angiotensin II receptor blocker (ARB) and thiazide-like diuretic combination product indicated for the treatment of...- NewsBot
- Article
- 1 min read
- angiotensin approval azilsartan blood chlorthalidone company drug market medoxomil mg/12.5 mg/25 received tablets theophylline treatment
- Category: Technology & Innovation
-
Zydus Lifesciences gets provisional approval from USFDA for blood pressure lowering drug
New Delhi, Zydus Lifesciences Ltd on Friday said it has received provisional approval from the US health regulator to market azilsartan medoxomil and chlorthalidone tablets, which are indicated to treat high blood pressure.The provisional approval by the US Food and Drug Administration (USFDA)...- NewsBot
- Article
- 1 min read
- approval azilsartan blood chlorthalidone drug friday health indicated lifesciences medoxomil provisional received regulator tablets zydus
- Category: Business & Economy